×
About 9,496 results

ALLMedicine™ Aspergillosis Center

Research & Reviews  4,475 results

Primary Cutaneous Aspergillosis in Immunocompetent Patients Due to Aspergillus niger: A...
https://doi.org/10.1097/DAD.0000000000001871
The American Journal of Dermatopathology; Pincelli MS, Sangueza M et. al.

May 7th, 2021 - Primary cutaneous aspergillosis is a cutaneous fungal infection due to the direct inoculation of spores of Aspergillus species into the disrupted skin. Primary cutaneous aspergillosis presents with a variety of localized cutaneous lesions, such as...

Next-Generation Sequencing-Based Decision Support for Intensivists in Difficult-to-Diag...
https://doi.org/10.1213/XAA.0000000000001447
A&A Practice; Kattner S, Herbstreit F et. al.

May 6th, 2021 - Aspergillus spp. are widespread environmental pathogens that can induce invasive aspergillosis, especially in immunocompromised patients. An 86-year-old female patient presented with a rare case of invasive cerebral aspergillosis. The aspergilloma...

An evolutionary genomic approach reveals both conserved and species-specific genetic el...
https://doi.org/10.1093/genetics/iyab066
Genetics Mead ME, Steenwyk JL et. al.

May 4th, 2021 - Aspergillosis is an important opportunistic human disease caused by filamentous fungi in the genus Aspergillus. Roughly 70% of infections are caused by Aspergillus fumigatus, with the rest stemming from approximately a dozen other Aspergillus spec...

Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus ...
https://doi.org/10.1128/AAC.00263-21
Antimicrobial Agents and Chemotherapy; Liang T, Yang X et. al.

May 4th, 2021 - Recently, mutations in the 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase gene (hmg1) have been identified to be associated with triazole resistance in Aspergillus fumigatus Here, we describe the first case of the G929C mutation in the...

Dynamic monitor of CT scan within short interval in invasive pulmonary aspergillosis fo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091757
BMC Pulmonary Medicine; Chen F, Zhong Y et. al.

May 4th, 2021 - In nonneutropenic patients with underlying respiratory diseases (URD), invasive pulmonary aspergillosis (IPA) is a life-threatening disease. Yet establishing early diagnosis in those patients remains quite a challenge. A retrospective series of no...

see more →

Guidelines  17 results

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 30th, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates a...
https://doi.org/10.1016/j.cmi.2019.05.019
Clinical Microbiology and Infection : the Official Public... Warris A, Lehrnbecher T et. al.

Jun 3rd, 2019 - Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer...

Information for Healthcare Professionals about Aspergillosis
https://www.cdc.gov/fungal/diseases/aspergillosis/health-professionals.html

Dec 31st, 2018 - Information for healthcare professionals about aspergillosis. Aspergillosis is a disease caused by Aspergillus, a common mold (a type of fungus) that lives indoors and outdoors. Most people breathe in Aspergillus spores every day without getting s...

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289
Therapeutic Drug Monitoring; Chen K, Zhang X et. al.

Sep 7th, 2018 - Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dos...

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-...
https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection : the Official Public... Ullmann AJ, Aguado JM et. al.

Mar 16th, 2018 - The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis. Of the numero...

see more →

Drugs  159 results see all →

Clinicaltrials.gov  4,719 results

Primary Cutaneous Aspergillosis in Immunocompetent Patients Due to Aspergillus niger: A...
https://doi.org/10.1097/DAD.0000000000001871
The American Journal of Dermatopathology; Pincelli MS, Sangueza M et. al.

May 7th, 2021 - Primary cutaneous aspergillosis is a cutaneous fungal infection due to the direct inoculation of spores of Aspergillus species into the disrupted skin. Primary cutaneous aspergillosis presents with a variety of localized cutaneous lesions, such as...

Voriconazole - voriconazole injection, powder, lyophilized, for solution-Slate Run Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f2e0784-8e48-f565-e053-2991aa0a0746

May 6th, 2021 - Voriconazole for injection is an azole antifungal indicated for use in the treatment of adults and pediatric patients aged 12 to 14 years weighing greater than or equal to 50 kg and those aged 15 years and older regardless of body weight with: Inv...

Next-Generation Sequencing-Based Decision Support for Intensivists in Difficult-to-Diag...
https://doi.org/10.1213/XAA.0000000000001447
A&A Practice; Kattner S, Herbstreit F et. al.

May 6th, 2021 - Aspergillus spp. are widespread environmental pathogens that can induce invasive aspergillosis, especially in immunocompromised patients. An 86-year-old female patient presented with a rare case of invasive cerebral aspergillosis. The aspergilloma...

Voriconazole - voriconazole tablet-Viona Pharmaceuticals Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75fcbea8-8eeb-4528-b7d9-a059dd25da83

May 5th, 2021 - Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients aged 12 to 14 years weighing greater than or equal to 50 kg and those aged 15 years and older regardless of body weight with: Invasive aspergillosis (...

An evolutionary genomic approach reveals both conserved and species-specific genetic el...
https://doi.org/10.1093/genetics/iyab066
Genetics Mead ME, Steenwyk JL et. al.

May 4th, 2021 - Aspergillosis is an important opportunistic human disease caused by filamentous fungi in the genus Aspergillus. Roughly 70% of infections are caused by Aspergillus fumigatus, with the rest stemming from approximately a dozen other Aspergillus spec...

see more →

News  117 results

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 26th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

The COVID Complication You Might Miss
https://www.medscape.com/viewarticle/940740_2

Nov 18th, 2020 - COVID-Associated Pulmonary Aspergillosis (CAPA)   CAPA is a recently recognized complication of COVID-19. Although aspergillosis is classically associated with severely immunocompromised patients, it is increasingly detected in patients who receiv...

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
https://www.mdedge.com/fedprac/article/171981/hematology/fatal-drug-resistant-invasive-pulmonary-aspergillus-fumigatus-56/page/0/2?channel=327

Aug 14th, 2019 - Conclusion This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he w.

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 3rd, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Disseminated invasive aspergillosis in an immunocompetent patient
https://www.mdedge.com/ccjm/article/201706/infectious-diseases/disseminated-invasive-aspergillosis-immunocompetent-patient?channel=162
Jessica McLaughlin, DO, Eric Libre, MD, FCCP et. al.

Jun 3rd, 2019 - A 57-year-old woman was admitted to our hospital for progressive hypoxic respiratory failure that developed after 10 days of empiric treatment at another hospital for an exacerbation of chronic obstructive pulmonary disease (COPD). Figure 1.

see more →

Patient Education  9 results see all →